A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, non-randomised study including patients with EBER positive
nasopharyngeal carcinoma with recurrent or metastatic disease not amenable to curative
treatment, who have received at least 1 regimen of platinum containing chemotherapy.